Page 420 - Safety Risk Management for Medical Devices
P. 420

Index  399


                   Potential Hazards, 79                    risk analysis, 93
                   Pre-risk, 162, 172                       safety standard, 171
                     controls, 162                        Production information, 193
                   Preclinical study, 185                 Production monitoring, 195 196, 198
                   Preliminary hazard analysis (PHA), 49, 74, 77 80,  benefits of postmarket surveillance, 199
                        172, 224 225, 286 308               feedback to preproduction risk management,
                     methodology, 78 80                        197 199
                       identify system hazards, 78 80       frequency of risk management file review, 197
                       safety characteristics, 78           postmarket risk management, 196 197
                     revisiting, 172                      Proper sizing, 38
                   Preproduction                          Protective measure, 144, 165, 173
                     phase, 195                           Protocol, 184
                     risk management, 196                 PubMed databases, 64
                       feedback to, 197 199               Pulley, 153
                   Pressure tank, 70                        failure mode of, 153f
                   Primary faults, 70
                   Primary function identification        Q
                     in DFMEA, 95                         QC testing. See Quality control testing (QC
                     in PFMEA, 104                             testing)
                     in UMFMEA, 113                       QMS. See Quality management system
                   Primary operating function, 32 34           (QMS)
                   Principal output of FTA, 68            Qualitative method, 157, 173 174
                   Probability, 19 20, 158t, 159t           risk evaluation for, 173
                     of benefit, 188 189                  Quality
                   Procedure-related harms, 189             of clinical data, 189
                   Process Failure Modes and Effects Analysis  system regulations, 4
                        (PFMEA), 80 81, 103 108           Quality control testing (QC testing), 175 176
                     detectability ratings, 109t, 265, 318 324  Quality management system (QMS), 29, 52, 177
                     occurrence ratings, 108t             Quantitative analysis, 69 70
                     RPN table, 109t                      Quantitative method, 159 161, 174
                     template, 250 254                      risk evaluation for, 174
                     workflow, 104 108                    Quantitative risk
                       analysis, 105 108                    estimation, 47
                       identify primary and secondary functions,  management method, 174
                        104
                       PFD, 104 105                       R
                       set scope, 104                     RACT. See Risk Assessment and Control Table
                   Process flow diagram (PFD), 104 105         (RACT)
                   Process metrics, 219                   Ratings assigning, 114
                   Product                                Reasonableness checks, 38
                     description of Vivio, 265 266        Reasonably foreseeable misuse,
                     design process, 119                       12 13, 111
                     development                          Reliability, 121, 137, 147, 176
                       process, 221                       Residual risks
                       team, 169, 225                       estimation, 189
                     quality, 86                            individual and overall, 174
                     reliability, 86                      Risicare,15
                     requirements of Vivio, 266 267       Risk, 3 4, 11, 15, 157, 161, 163, 206
   415   416   417   418   419   420   421   422   423   424   425